on behalf of the COURAGE Investigators and Coordinators Background-The extent to which recurrent events in patients with stable coronary artery disease is attributable to progression of an index lesion originally Ն50% diameter stenosis (DS) but not revascularized or originally Ͻ50% DS is unknown during optimal medical therapy (OMT). Methods and Results-In the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial, 205 patients assigned to OMT plus percutaneous coronary intervention (PCI) and 284 patients assigned to OMT only had symptom-driven angiograms suitable for analysis. Percentages of patients in the OMTϩPCI and OMT-only cohorts with index lesions originally Ͻ50% DS were 30% and 32%, respectively; 20% and 68% had index lesions originally Ն50% DS. In both groups, index lesions originally Ͻ50% or Ն50% DS represented Ͻ4% and Ͻ25% of all such lesions, respectively. The only angiographic predictor of myocardial infarction or acute coronary syndrome was the number of lesions originally Ն50% DS that had not been revascularized (odds ratio, 1.15; confidence limits, 1.01-1.31; PϽ0.04). Conclusions-Lesions originally Ͻ50% DS were index lesions in one third of patients referred for symptom-driven repeat angiography, but represented Ͻ4% of all such lesions. Nonrevascularized lesions originally Ն50% DS were more often index lesions in OMT-only patients, but still represented a minority (Ͻ25%) of all such lesions. These findings underscore the need for improved therapies to arrest plaque progression and reliable strategies for selecting stenoses warranting PCI. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00007657. (Circ Cardiovasc Interv. 2011;4:545-552.)
assess the extent to which worsening symptoms warranting clinically driven coronary angiography are associated with progression of lesions originally Ͻ50% or Ն50% diameter stenosis (DS) but not revascularized in the setting of contemporary OMT.
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WHAT IS KNOWN
• Acute coronary syndromes are believed to arise commonly from lesions Ͻ50% diameter stenosis.
• Prognosis in patients with coronary disease is related to overall atherosclerosis burden.
WHAT THE STUDY ADDS
• In patients treated with optimal medical therapy, symptoms that developed during follow-up were attributed to progression of lesions originally Ͻ50% diameter stenosis in one third of patients.
• Lesions Ͻ50% that progressed represented Ͻ4% of all such lesions.
• In patients treated with optimal medical therapy and percutaneous coronary intervention, lesions originally Ն50% diameter stenosis were responsible for new symptoms in 20% of patients and 68% in optimal medical therapy-only patients. • The number of nonrevascularized lesions originally Ն50% diameter stenosis was the only angiographic predictor of myocardial infarction or acute coronary syndrome.
Methods
Angiographic methods and use of OMT in COURAGE have been described previously. 3, 4 There were no prespecified indications for repeat coronary angiography. Repeat angiography was symptom driven and performed in the setting of an acute coronary syndrome (ACS), when angina was inadequately controlled by maximal medical therapy, when evidence of worsening ischemia on noninvasive testing was noted, or when the treating physician believed that other clinical features justified the procedure. However, investigators were encouraged to avoid crossover from the OMT-only to the OMT plus percutaneous coronary intervention (PCI) cohort as well as excessive repeat PCI in the OMTϩPCI cohort, both of which would have undermined the integrity of the study. The core angiography laboratory was notified of a second angiogram for 507 patients. Eighteen were excluded as follows: Six follow-up angiograms could not be analyzed (corrupted disc files); 4 patients randomized to the OMT-alone group had a PCI on the same day as randomization; 7 patients had coronary artery bypass graft (CABG) surgery during follow-up, but the preoperative angiogram could not be located; and 1 patient was assigned to OMTϩPCI, but staged PCI did not occur because of an intervening myocardial infarction (MI). Thus, 489 patients were included in this study.
Angiographic Index Lesions
During follow-up angiography, a single index lesion was identified for each patient and considered to be the lesion most likely to be responsible for the change in symptom status. The index lesion was either the worst stenosis undergoing PCI or the worst stenosis if no PCI was performed. If Ͼ1 lesion of worst severity was present, the 1 with the greatest change in %DS from baseline was selected. An occluded segment not revascularized at baseline that remained occluded in the follow-up angiogram was not considered to be the index lesion, even if intervention occurred at follow-up, because the clinical deterioration was assumed to be due to progression in other lesions. The single index lesion per patient was referenced to the baseline angiogram as being either a restenotic lesion, a lesion originally Ͻ50% DS, or a nonrevascularized lesion originally Ն50% DS.
Angiographic Disease Burden
Vessel disease was determined by lesions originally Ն50% DS in the main coronary segments of the right coronary artery, left anterior descending coronary artery (LAD), and left circumflex artery (LCX); their main branches (first or largest diagonal of LAD, first or largest obtuse marginal branch of left circumflex artery, posterior descending branch of a dominant right coronary or left circumflex artery); or the left main or bypass grafts perfusing these arterial distributions. Patients were categorized as having single-, double-, and triplevessel disease; disease in the right coronary artery, LAD, or left circumflex artery (including all combinations), and presence or absence of proximal LAD disease. A modified Duke Jeopardy Score also was calculated. 3 
Clinical Events
Death, MI (excluding periprocedural MI), hospitalization for ACS, and revascularization occurring between the baseline angiogram and up to 2 months after the follow-up angiogram were recorded. 1
Statistical Analysis
Where appropriate, comparisons were made using t tests, MannWhitney tests, Kolmogorov-Smirnov tests, Fisher exact tests, 2 tests, Kruskal-Wallis nonparametric ANOVA, and single-factor ANOVA to compare groups having either MI/ACS/PCI, PCI only, or symptoms only. Forward, stepwise, multiple logistic regression analysis was used to determine independent predictors of MI/ACS and MI/ACS/PCI. Variables in the logistic regressions were included because of their known clinical importance or because univariate comparisons (reported later herein) showed PՅ0.15. The variables were sex, age, Canadian Cardiovascular Society angina class, assignment to OMT-only or OMTϩPCI group, low-density lipoprotein level at baseline and before the second angiogram, number of vessels diseased, left ventricular ejection fraction, presence or absence of prior CABG, presence or absence of proximal LAD disease, average original %DS, average number of nonrevascularized lesions originally Ն50% DS, average %DS of lesions originally Ն50% DS, average number of lesions originally Ͻ50%, and average number of PCI lesions at baseline. Data are reported as meanϮSE or as medians with interquartile ranges (IQRs). A PϽ0.05 was considered significant. Table 1 shows a comparison of demographic features between patients with and without a second angiogram. Patients in this report had higher total and low-density lipoprotein cholesterol, higher Canadian Cardiovascular Society class, and more prior CABGs. The 18 patients with unsuitable angiographic data were slightly younger than the patients included in this analysis. Table 2 shows a comparison of patients according to randomization. The OMT-only group had slightly higher total cholesterol at baseline. 
Results
Baseline Characteristics
Timing of Presentation
Index Lesions According to Randomization
In the OMTϩPCI cohort ( Figure 1A ), index lesions were originally Ͻ50% DS in 61 (29.8%) patients and originally Ն50% DS in 42 (20.0%) patients, and the remainder were restenosis lesions. However, only 3.4% of lesions originally Ͻ50% DS and only 11.8% of lesions originally Ն50% DS and not revascularized were index lesions on the follow-up angiogram ( Figure 1B ). For the OMT-only cohort, index lesions were originally Ͻ50% DS in 92 (32.4%) patients, but these represented only 3.4% of all lesions originally Ͻ50% DS (Figure 2A and 2B ). There were 192 (67.6%) patients with index lesions originally Ն50% DS in the OMT-only cohort, but these represented only 24.6% of lesions originally Ն50% DS and not revascularized.
Index Lesions and Clinical Events
One hundred thirty patients from either cohort had PCI in the setting of MI (total, 67; OMT-only group, 44) or ACS (total, 63; OMT-only group, 39), 222 had PCI only, and 137 had symptom deterioration but no MI/ACS/PCI. No patient had additional angiography, PCI, or CABG or died up to 2 months after the follow-up angiogram. Thus, the follow-up angiogram was temporally relevant to the clinical status and adjudicated end points examined in this study. Table 3 shows the baseline and follow-up severity of index lesions with respect to occurrence of MI/ACS, PCI only, or symptoms only. In general, index lesions originally Ͻ50% DS were 28% to 39% DS at baseline and 58% to 69% DS at follow-up. Data are presented as meanϮSE or %. OMT indicates optimal medical therapy; PCI, percutaneous coronary intervention; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MI, myocardial infarction; CCS, Canadian Cardiovascular Society; CABG, coronary artery bypass graft.
Severity of these lesions was significantly greatest in patients with an MI/ACS (69Ϯ3% DS) and least in those with symptoms only (59Ϯ2% DS; PϽ0.02). Restenosis lesions also showed substantial change (baseline, 24%-33% DS; follow-up, 72%-76% DS). Index lesions from nonrevascularized lesions originally Ն50% DS progressed minimally, showing baseline severity of 59% to 68% DS and follow-up severity of 64% to 80% DS. When considering all patients, the groups with MI/ACS and PCI only showed the same distribution of index lesions, whereas the group having symptoms only had a lower proportion of index lesions originally Ն50% DS (PϽ0.05). Furthermore, there were no differences between patients with MI and ACS (data not shown). Accordingly, patients with MI/ACS/PCI are reported in aggregate in Figure 3A and 3B. Although more than one half of the patients had MI/ACS/PCI in association with an index lesion originally Ն50% DS, these represented only 20.7% of all such lesions at baseline. Index lesions originally Ͻ50% DS were seen in 29.3% of patients, but these represented only 3.2% of all such lesions at baseline. Figure 4A and 4B show index lesions originally Ͻ50% DS or Ն50% DS in nearly equal proportions of patients with symptoms only. These represented only 20.0% of lesions originally Ն50% DS and only 3.9% of all lesions originally Ͻ50% DS. Table 4 summarizes several angiographic features that differed significantly in univariate analyses among the groups with MI/ACS, PCI only, and symptoms only. Patients assigned to OMT only were more likely to undergo PCI during the follow-up angiogram than patients assigned to OMTϩPCI, as were patients with prior CABG. Patients having PCI with or without associated MI/ACS had evidence of more severe angiographic disease, including a higher number of nonrevascularized lesions originally Ն50% DS, a higher %DS of these lesions, and a higher average %DS of all lesions. There were no differences among groups based on left ventricular ejection fraction, Duke Jeopardy Score, number of diseased vessels, location of significant stenoses, presence or absence of proximal LAD disease, number of lesions originally Ͻ50% DS, or number of PCI lesions in the OMTϩPCI group (data not shown). 
Discussion
This study is the first descriptive angiographic analysis of patients enrolled in the COURAGE trial who were treated with aggressive, contemporary, evidence-based pharmacological and lifestyle therapy, whose clinical events were adjudicated, and in whom follow-up coronary angiograms performed because of symptom progression were available and suitable for analysis. The patients receiving OMT alone are unique because PCI was deferred for all significant lesions until symptom change warranted repeat angiography. Importantly, all patients with symptom progression and suitable angiograms are reported, not just those who underwent a follow-up revascularization or who experienced an event, thereby allowing for a careful and balanced assessment of the importance of the origin of index lesions associated with a full spectrum of symptom progression.
There are 4 main findings. First, symptom progression over the longest term (median, 1.2 years) was associated with an index lesion originally Ͻ50% DS in one third of patients despite contemporary OMT or prior PCI. Second, the association of symptom progression with nonrevascularized lesions originally Ն50% DS was more variable and dependent on whether PCI was performed initially. Such lesions accounted for 20% of cases of symptom progression in OMTϩPCI patients but 68% in the OMT-only patients and presented almost as early as cases with restenosis lesions (0.6 years). Third, index lesions represented Ͻ4% of lesions originally Ͻ50% DS and Ͻ25% of nonrevascularized lesions originally Ն50% DS. Even in patients with MI/ACS/PCI during follow-up, nonrevascularized lesions originally Ն50% DS represented Ͻ21% of all such lesions at baseline. Accordingly, the ability to recognize either type as a potential index lesion is problematic, especially identification of vulnerable plaques among lesions originally Ͻ50% DS. Finally, the only independent angiographic risk factor for MI/ACS was the number of nonrevascularized lesions originally Ն50% DS, not the number of lesions originally Ͻ50% DS or any other angiographic parameter.
Identification of Vulnerable Plaques
A major thrust of current research is targeted toward identification of vulnerable plaques destined to become index lesions. 5 This has been driven by classic pathological and angiographic observations suggesting that ACS is most commonly associated with rupture of mild angiographic stenoses. However, the incidence of this association is quite wide, ranging from a low of Ͻ10% 6 to a high of almost two thirds. 7 The recently reported PROSPECT (Providing Regional Ob- servations to Study Predictors of Events in the Coronary Tree) trial was undertaken to link imaging features of plaques with subsequent events in patients successfully treated for ACS with contemporary medications. 8 Angiographically mild lesions on intravascular ultrasound and virtual histology showing a thin fibroatheroma cap, a large necrotic core, Ͼ70% plaque area, and a minimum lumen area Ͻ4 mm 2 imparted the greatest risk during follow-up. One half of new events (mainly rehospitalization for unstable or progressive angina) were associated with mild angiographic lesions undergoing rapid progression. By contrast, we found that a minority (one third) of patients had symptom progression associated with index lesions that were originally Ͻ50% DS, and the time of presentation was relatively long. These differences are likely due to differences in the identification of the lesions (intravascular ultrasound versus angiography); clinical presentation (ACS versus stable coronary artery disease); the predominant use of bare-metal stents in COURAGE; and perhaps most importantly, the intensity of OMT used in COURAGE. 4 The key conclusion, however, is that symptom progression due to progression of mild angiographic lesions during the follow-up care of patients with coronary artery disease is substantial despite contemporary OMT.
Some studies have suggested that vulnerable plaques might be identified noninvasively. 5,9 -11 One of the most ambitious studies in this arena used coronary CT angiography to examine putative predictive features (plaques with positive remodeling and with low attenuation) in Ͼ10 000 lesions. 9 Patients harboring plaques with both features had the highest risk of ACS within 24 months of study. However, the majority with 1 or both features had no ACS, and ACS was seen even when these features were absent. Even more sobering was the extremely low incidence of plaques with features of vulnerability (74 such plaques of Ͼ10 000 plaques). This Ͻ1% frequency in asymptomatic subjects, the poor predictive value of morphological features of vulnerability, and the Ͻ4% frequency of index lesions originally Ͻ50% DS in the current study all suggest that identification of these vulnerable plaques is less important than the discovery of new, systemic therapies that can prevent progression and destabilization more effectively than current OMT. 12 This is a key element of residual risk in patients with coronary artery disease. 13 
Identification of Obstructive Lesions That Become Index Lesions
Both the COURAGE and the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trials support an initial strategy of OMT only followed by elective revascularization when warranted to manage residual symptoms. 1, 14 Even when warranted for symptoms, there remains the additional challenge of selecting which lesions merit revascularization. The traditional concept of complete, anatomic revascularization was challenged by the FAME (Flow Reserve versus Angiography for Multivessel Evaluation) study, which promoted PCI solely for those lesions shown to be of hemodynamic importance as assessed by fractional flow reserve (FFR). 15 The 2-year results of FAME showed that FFR-guided PCI compared with an angiographic, stenosisguided strategy offers an economic advantage as well as an improvement in the composite end point of death and MI. 16 The findings from FAME also suggested that restenosis and new lesions are more important determinants of clinical course than nonrevascularized lesions Ն50% DS with normal FFR. 15, 16 Our analyses of the OMTϩPCI cohort are concordant with the FAME observations: Restenosis plus progression of mild lesions accounted for 80% of cases with symptom progression, only 20% of all nonrevascularized lesions originally Ն50% DS were identified as index lesions, and these index lesions progressed minimally compared with mild lesions and restenosis lesions. However, the reduction of death and MI using FFR-guided compared with angiographic-guided PCI still requires confirmation because the main results of COURAGE demonstrated that all lesions Ն50% DS could safely be deferred while implementing OMT without incurring a higher long-term risk of death and MI/ACS, even without FFR. 1,3 Furthermore, we have previously shown in COURAGE patients randomized to OMTϩPCI that those with complete revascularization of lesions Ն50% DS tended to have an improved outcome that emerged only after 2 years of follow-up. 3 This is concordant with the current multivariable analyses showing the prognostic importance of the number of deferred lesions for predicting MI/ACS. Thus, further studies are needed to determine whether angiographic-or FFR-guided revascularization strategies are optimal over the long term. The current finding that not Ͼ25% of all nonrevascularized lesions Ն50% DS could ultimately be identified as index lesions suggests that FFR may be both practical and useful for identifying this subset of angiographically obstructive lesions. Importantly, background OMT is mandatory to ensure that the burden of new lesions over the long term does not detract from the assessment of the full value of an FFR-guided strategy.
Prognostic Importance of Angiographic Features
Independent predictors of MI/ACS/PCI (OMT only, prior CABG, and severe Canadian Cardiovascular Society class) are largely driven by the fact that revascularization, especially with PCI, would be the main residual option once OMT failed. The independent importance of low-density lipoprotein level is similar to the findings of Glaser et al, 6 but the present results must be viewed cautiously because of the very low OR and nominal P value. Notably, no angiographic features were of independent importance. However, when follow-up PCI was excluded as an event, the only independent angiographic predictor of MI/ACS was the number of lesions originally Ն50% DS that were not revascularized, with no independent effect of the number of mild lesions. The number of nonrevascularized lesions originally Ն50% DS is obviously closely related to typical definitions of vessel disease (single, double, and triple) as well as other measures of disease burden, such as Duke Jeopardy Score, average %DS, and so forth. The finding is concordant with previously reported COURAGE angiographic findings showing that event rates escalate in parallel with increased angiographic disease burden even in the face of contemporary OMT supplemented by either initial or clinically driven revascularization. 1, 3 Thus, angiographic disease burden remains a strong marker for events, even though the underlying index lesion in a given patient may not arise from angiographically significant lesions.
Study Limitations
This retrospective, descriptive study was limited to patients with a clinically driven repeat angiogram that was suitable for Data are presented as meanϮSE or n (%). MI indicates myocardial infarction; ACS, acute coronary syndrome; PCI, percutaneous coronary intervention; OMT, optimal medical therapy; CABG, coronary artery bypass graft; DS, diameter stenosis.
identification of an index lesion. Because the majority of patients in the main trial did not have a second angiogram, selection bias may have exaggerated the current angiographic findings. This effect was somewhat mitigated by inclusion of all patients with symptom deterioration who were not experiencing MI/ACS or undergoing PCI within 2 months of the second angiogram. Although identification of the index lesion in this group may be viewed as more tenuous, the types of index lesions underlying all categories of symptom progression were fairly similar ( Table 3 ). The study cohort was more symptomatic, had more patients with CABG, and had higher cholesterol than patients enrolled in COURAGE who did not have repeat angiography. However, these imbalances were included in our multivariable analyses, and the distribution of vessel disease as well as all other important demographic features were the same (Table 1) . Stenosis features other than %DS were not recorded, but Glaser et al 6 failed to show that such features provided discriminatory information in predicting the need for repeat procedures in a large cohort of patients. Absence of FFR data precludes us from identifying which of the lesions that became index lesions might also have been associated with an abnormal FFR. Absence of intravascular ultrasound precludes us from correlating index lesions arising from lesions originally Ͻ50% DS that might also have had classic features of vulnerability or substantial atheroma burden. However, the angiographic progression of such lesions during OMT noted in the current study remains an observation of critical clinical relevance even in the absence of intravascular ultrasound information.
Conclusions
This analysis provides an assessment of angiographic progression of lesions underlying symptom progression during contemporary OMT. It shows that approximately one third of patients with symptom progression over the long term have an index lesion originally Ͻ50% DS that has undergone progression or destabilization. New systemic therapies to prevent this important element of residual risk are critically needed and may emerge from detailed understanding of the biology of vulnerable plaques. Nonrevascularized lesions originally Ն50% DS were the only angiographic predictor of MI/ACS, but Ͻ25% of all such lesions were identified as subsequent index lesions. Thus, it is critically important to establish the long-term value of FFR for selecting lesions for PCI in studies using aggressive and contemporary OMT as background therapy.
